腺素A2A受体基因多态性 (ADORA2A) 与最大的集中收缩疼痛有关
Patrick J O'Connor1, Bryan D Loy2, Jacob B Lindheimer3,4,5
1Department of Kinesiology, University of Georgia, Athens, GA 30602, United States.
Meta gene
|August 10, 2023
概括
氨酸A2A受体基因 (ADORA2A) 变异与强烈收缩期间的肌肉疼痛有关. 这一发现表明,在未受伤的肌肉中影响疼痛感知的一种遗传成分.
科学领域:
- 遗传学 遗传学 是一个
- 运动生理学 运动生理学
- 疼痛研究 疼痛研究
背景情况:
- 腺A2A受体 (ADORA2A) 在各种生理过程中发挥作用,包括疼痛调节.
- 在ADORA2A中的遗传变异可能会影响疼痛感知和对肌肉损伤的反应的个体差异.
研究的目的:
- 为了研究ADORA2A基因多态化与最大肌肉收缩期间的疼痛之间的关联.
- 为了检查ADORA2A多态度对咖啡因诱导的感知变化和对肌肉损伤的反应的影响.
主要方法:
- 进行了一项针对性候选基因关联研究.
- 在26名成年人中进行了ADORA2A (rs5751876) 的基因定型.
- 评估了肘部最大曲器收缩期间的疼痛,咖啡因/安慰剂效应以及肌肉损伤反应 (手臂体积,炼).
主要成果:
- 与CT/TT组相比,CC基因型组的最大集中收缩疼痛明显高于CT/TT组 (d = 0.89).
- 相反,与CT/CC组相比,TT基因型组的疼痛程度较低 (d = 0.62).
- 在CC和TT/CT组之间观察到中等程度的差异,包括受伤后的运动和24小时后的手臂体积.
结论:
- 在未受伤的个体中,ADORA2A多态表现出在最大收缩期间与肌肉疼痛的中度关联.
- 这些发现表明,ADORA2A的遗传变异可能导致疼痛敏感度的差异.
关键词:
在A2A受体中,A2A受体是在ADORA2A中,使用的是ADORA2A.亚丁氨酸 (Adenosine) 是一种氨基酸.咖啡因 咖啡因是一种咖啡因.奇特的运动 奇特的运动疼痛 疼痛 疼痛 疼痛更多相关视频
相关概念视频
Adrenergic Receptors: ɑ Subtype
1.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.6K
Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
888
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
888
Adrenergic Receptors (Adrenoceptors): Classification
2.7K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
780
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
780
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
922
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
922


